GCT Semiconductor Holding, Inc.

For the period ended Dec 31, 2024. Filed Mar 25, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 25, 2025

GCTS$1.45+5.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholder’s Deficit

Accumulated
Additional · Other · Total
Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders’
	Shares	Amount	Capital	Income	Deficit	Deficit
Balance as of December 31, 2022	127,761	$128	$433,990	$(1,862)	$(527,185)	$(94,929)
Effect of reverse recapitalization	(103,900)	(126)	126	—	—	—
Balance as of December 31, 2022(1)	23,861	2	434,116	(1,862)	(527,185)	(94,929)
Issuance of common stock upon exercise of stock options	210	1	22	—	—	23
Issuance of common stock from conversion of promissory notes and accrued interest	15	—	72	—	—	72
Issuance of common stock from warrant exercise	80	—	1,499	—	—	1,499
Stock-based compensation	—	—	43	—	—	43
Foreign currency translation adjustment	—	—	—	324	—	324
Net loss	—	—	—	—	(22,469)	(22,469)
Balance as of December 31, 2023(1)	24,166	$3	$435,752	$(1,538)	$(549,654)	$(115,437)

Accumulated
Additional · Other · Total
Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders’
	Shares	Amount	Capital	Income (Loss)	Deficit	Deficit
Balance as of December 31, 2023	129,396	$129	$435,626	$(1,538)	$(549,654)	$(115,437)
Effect of reverse recapitalization	(105,230)	(126)	126	—	—	—
Balance as of December 31, 2023(1)	24,166	3	435,752	(1,538)	(549,654)	(115,437)
Reverse recapitalization transaction, net of transaction costs and acquired liabilities	21,667	2	50,031	—	—	50,033
Issuance of common stock under common stock purchase agreement	2,364	—	9,790	—	—	9,790
Issuance of commitment shares in connection with common stock purchase agreement	57	—	—	—	—	—
Issuance of common stock to underwriter	110	—	667	—	—	667
Issuance of common stock and common stock warrants in a private placement	742	—	2,240	—	—	2,240
Issuance of common stock upon exercise of stock options	133	—	15	—	—	15
Release of vested restricted stock units	98	—	—	—	—	—
Forfeiture of unvested sponsor earnout shares	(1,350)	—	—	—	—	—
Stock-based compensation	—	—	2,700	—	—	2,700
Foreign currency translation adjustment	—	—	—	3,056	—	3,056
Net loss	—	—	—	—	(12,379)	(12,379)
Balance as of December 31, 2024	47,987	$5	$501,195	$1,518	$(562,033)	$(59,315)

(1)

Amounts as of December 31, 2023 and before that date differ from those in prior year consolidated financial statements as they were retrospectively adjusted as a result of the accounting for the Business Combination (as defined in the Notes to the Consolidated Financial Statements).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.